Much more than 50% from the sufferers obtained largely anthracycline-centered chemotherapy in the course of pregnancy. Fetal outcome was comparable between the teams with or with no chemotherapy, as was the outcome of people owning chemotherapy throughout or after delivery. The authors conclude that untimely supply which may enhance fetal morbidity